Literature DB >> 31453554

Is kinesiophobia associated with lymphedema, upper extremity function, and psychological morbidity in breast cancer survivors?

Aslı Gencay Can1, Serdar Süleyman Can2, Emel Ekşioğlu1, Fatma Aytül Çakcı1.   

Abstract

OBJECTIVES: This study aims to the effects of kinesiophobia on lymphedema, upper extremity function, depression/anxiety, and quality of life in breast cancer survivors. PATIENTS AND METHODS: Between January 2015 and January 2016, a total of 81 breast cancer survivors (mean age 54.1±10.8 years; range 44 to 70 years) were included. Lymphedema was evaluated based on the circumference measurements. The Tampa Scale for Kinesiophobia (TSK), the Quick Disabilities of Arm, Shoulder, and Hand (Q-DASH) Questionnaire, the Hospital Anxiety and Depression Scale (HADS), and the Short Form-36 (SF-36) were applied to all patients.
RESULTS: We found a significantly higher rate of lymphedema in the patients with kinesiophobia. Kinesiophobic patients had also significantly higher mean scores of TSK, Q-DASH, HADS-A, and HADS-D and lower mean scores of the SF-36 physical scores. Correlation analysis demonstrated that presence of lymphedema, Q-DASH, HADS-A, and HADS-D scores were significantly associated with the TSK scores.
CONCLUSION: Kinesiophobia increases the risk for lymphedema, depression/anxiety, and decreased upper extremity functioning in breast cancer survivors. Identifying kinesiophobia in breast cancer survivors, psychosocial providers may help to prevent undesirable effects of kinesiophobia.

Entities:  

Keywords:  Breast cancer; kinesiophobia; lymphedema; upper extremity functioning

Year:  2018        PMID: 31453554      PMCID: PMC6706825          DOI: 10.5606/tftrd.2019.2585

Source DB:  PubMed          Journal:  Turk J Phys Med Rehabil        ISSN: 2587-1250


  29 in total

1.  Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population.

Authors:  Inger Schou; Øivind Ekeberg; Leif Sandvik; Marianne J Hjermstad; Cornelia M Ruland
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  Reliability and construct validity of the SF-36 in Turkish cancer patients.

Authors:  Rukiye Pinar
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

Review 3.  Exercise for the management of cancer-related fatigue in adults.

Authors:  F Cramp; J Daniel
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 4.  Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials.

Authors:  Ruud Knols; Neil K Aaronson; Daniel Uebelhart; Jaap Fransen; Geert Aufdemkampe
Journal:  J Clin Oncol       Date:  2005-06-01       Impact factor: 44.544

5.  Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study.

Authors:  Patricia A Ganz; Katherine A Desmond; Beth Leedham; Julia H Rowland; Beth E Meyerowitz; Thomas R Belin
Journal:  J Natl Cancer Inst       Date:  2002-01-02       Impact factor: 13.506

6.  Prospective trial of intensive decongestive physiotherapy for upper extremity lymphedema.

Authors:  Didem Karadibak; Tugba Yavuzsen; Serdar Saydam
Journal:  J Surg Oncol       Date:  2008-06-01       Impact factor: 3.454

7.  Physical activity levels among breast cancer survivors.

Authors:  Melinda L Irwin; Anne McTiernan; Leslie Bernstein; Frank D Gilliland; Richard Baumgartner; Kathy Baumgartner; Rachel Ballard-Barbash
Journal:  Med Sci Sports Exerc       Date:  2004-09       Impact factor: 5.411

8.  Pain catastrophizing and kinesiophobia: predictors of chronic low back pain.

Authors:  H Susan J Picavet; Johan W S Vlaeyen; Jan S A G Schouten
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

9.  Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study.

Authors:  K Johansson; K Ohlsson; C Ingvar; M Albertsson; C Ekdahl
Journal:  Lymphology       Date:  2002-06       Impact factor: 1.286

10.  Predictive value of fear avoidance in developing chronic neck pain disability: consequences for clinical decision making.

Authors:  Marc J Nederhand; Maarten J Ijzerman; Hermie J Hermens; Dennis C Turk; Gerrit Zilvold
Journal:  Arch Phys Med Rehabil       Date:  2004-03       Impact factor: 3.966

View more
  5 in total

1.  Role of physiotherapy in supporting recovery from breast cancer treatment: a qualitative study embedded within the UK PROSPER trial.

Authors:  Sophie Rees; Bruno Mazuquin; Helen Richmond; Esther Williamson; Julie Bruce
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

2.  Ultrasound use in metastatic breast cancer to measure body composition changes following an exercise intervention.

Authors:  Adrian Escriche-Escuder; Manuel Trinidad-Fernández; Bella Pajares; Marcos Iglesias-Campos; Emilio Alba; Antonio I Cuesta-Vargas; Cristina Roldán-Jiménez
Journal:  Sci Rep       Date:  2021-04-23       Impact factor: 4.379

3.  Functional evaluation of patients with mastectomy lymphedema.

Authors:  Yıldız Erdoğanoğlu; Meryem Çalık; Meltem Vural
Journal:  Turk J Phys Med Rehabil       Date:  2021-03-04

4.  Polish Adaptation of the Modified Tampa Scale of Kinesiophobia for Fatigue (TSK-F) and the Revision of the Tampa Scale in Terms of Pain for Cancer Patients.

Authors:  Mateusz Rozmiarek; Mateusz Grajek; Ewa Malchrowicz-Mośko; Karolina Sobczyk; Karolina Krupa-Kotara; Piotr Nowaczyk; Janusz Wasiewicz; Tomasz Urbaniak; Wojciech Siejak; Urszula Czerniak; Anna Demuth; Aitor Martínez Aguirre-Betolaza; Arkaitz Castañeda-Babarro
Journal:  Int J Environ Res Public Health       Date:  2022-10-05       Impact factor: 4.614

5.  Work Ability after Breast Cancer: Study of Healthcare Personnel Operating in a Hospital of South Italy.

Authors:  Francesca Vella; Veronica Filetti; Luigi Cirrincione; Venerando Rapisarda; Serena Matera; Alenka Skerjanc; Emanuele Cannizzaro; Ermanno Vitale
Journal:  Int J Environ Res Public Health       Date:  2022-08-31       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.